Clinical trial design optimisation and dose rationale for the treatment of Buruli Ulcer antibiotic combination therapy

被引：0
|
作者：
D'Agate, Salvatore [1 ]
Garcia Barrios, Noelia [1 ]
Millan Placer, Ana Cristina [2 ]
Lucia Quintana, Ainhoa [2 ]
Ramon Garcia, Santiago [3 ]
Della Pasqua, Oscar [4 ]
机构：
[1] UCL, London, England
[2] Univ Zaragoza, Zaragoza, Spain
[3] Fdn ARAID, Zaragoza, Spain
[4] GlaxoSmithKline, Munich, Germany
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2021年 / 87卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
OC016
引用
收藏
页码：4882 / 4882
页数：1
相关论文
共 50 条
  • [41] Rationale and options for combination therapy in the treatment of Type 2 diabetes
    Van Gaal, LF
    De Leeuw, IH
    DIABETOLOGIA, 2003, 46 (Suppl 1) : M44 - M50
  • [42] Rationale and options for combination therapy in the treatment of Type 2 diabetes
    L. Van Gaal
    I. De Leeuw
    Diabetologia, 2003, 46 : M44 - M50
  • [43] A MULTIFACTORIAL TRIAL DESIGN TO ASSESS COMBINATION THERAPY IN HYPERTENSION - TREATMENT WITH BISOPROLOL AND HYDROCHLOROTHIAZIDE
    FRISHMAN, WH
    BRYZINSKI, BS
    COULSON, LR
    DEQUATTRO, VL
    VLACHAKIS, ND
    MROCZEK, WJ
    DUKART, G
    GOLDBERG, JD
    ALEMAYEHU, D
    KOURY, K
    ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (13) : 1461 - 1468
  • [44] A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis
    El Setouhy, M
    Ramzy, RMR
    Ahmed, ES
    Kandil, AM
    Hussain, O
    Farid, HA
    Helmy, H
    Weil, GJ
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2004, 70 (02): : 191 - 196
  • [45] Antibiotic treatment outcomes of Buruli ulcer in Akwapem South and Suhum-Kraboa-Coaltar districts of Eastern region, Ghana
    Kotey, N. K.
    Ampadu, X.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 195 - 195
  • [46] Dynamics of the Cytokine Response to Mycobacterium ulcerans during Antibiotic Treatment for M-ulcerans Disease (Buruli Ulcer) in Humans
    Sarfo, F. S.
    Phillips, R. O.
    Ampadu, E.
    Sarpong, F.
    Adentwe, E.
    Wansbrough-Jones, M.
    CLINICAL AND VACCINE IMMUNOLOGY, 2009, 16 (01) : 61 - 65
  • [47] Additive triple DMARD combination therapy of a low dose of sulfhydryl compounds, sulfasalazine and methotrexate in the treatment of rheumatoid arthritis: A clinical trial
    Nishiya, K
    Hisakawa, N
    Tahara, K
    Matsumori, A
    Ito, H
    Hashimoto, K
    Nakatani, K
    Takatori, K
    ACTA MEDICA OKAYAMA, 1999, 53 (06) : 275 - 279
  • [48] Rationale and design of the AngeLmed for Early Recognition and Treatment of STEMI trial: A randomized, prospective clinical investigation
    Gibson, Michael C.
    Krucoff, Mitchell
    Fischell, David
    Fischell, Tim A.
    Keenan, David
    Abueg, Cassandra
    Patel, Charmaine
    Holmes, David
    AMERICAN HEART JOURNAL, 2014, 168 (02) : 168 - 174
  • [49] Design, rationale, and baseline characteristics of a pilot randomized clinical trial of nicotine treatment for pulmonary sarcoidosis
    Hade, Erinn M.
    Smith, Rachel M.
    Culver, Daniel A.
    Crouser, Elliott D.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2020, 20
  • [50] Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations
    Povsic, Thomas J.
    Henry, Timothy D.
    Ohman, E. Magnus
    Pepine, Carl J.
    Crystal, Ronald G.
    Rosengart, Todd K.
    Reinhardt, Rickey R.
    Dittrich, Howard C.
    Traverse, Jay H.
    Answini, Geoffrey A.
    Mokadam, Nahush A.
    AMERICAN HEART JOURNAL, 2021, 241 : 38 - 49
12345